Literature DB >> 1410280

Identification of nitroxide radioprotectors.

S M Hahn1, L Wilson, C M Krishna, J Liebmann, W DeGraff, J Gamson, A Samuni, D Venzon, J B Mitchell.   

Abstract

The nitroxide Tempol, a stable free radical, has recently been shown to protect mammalian cells against several forms of oxidative stress including radiation-induced cytotoxicity. To extend this observation, six additional water-soluble nitroxides with different structural features were evaluated for potential radioprotective properties using Chinese hamster V79 cells and clonogenic assays. Nitroxides (10 mM) were added 10 min prior to radiation exposure and full radiation dose-response curves were determined. In addition to Tempol, five of the six nitroxides afforded in vitro radioprotection. The best protectors were found to be the positively charged nitroxides, Tempamine and 3-aminomethyl-PROXYL, with protection factors of 2.3 and 2.4, respectively, compared with Tempol, which had a protection factor of 1.3. 3-Carboxy-PROXYL, a negatively charged nitroxide, provided minimal protection. DNA binding characteristics as studied by nonequilibrium dialysis of DNA with each of the nitroxides demonstrated that Tempamine and 3-amino-methyl-PROXYL bound more strongly to DNA than did Tempol. Since DNA is assumed to be the target of radiation-induced cytotoxicity, differences in protection may be explained by variabilities in affinity of the protector for the target. This study establishes nitroxides as a general class of new nonthiol radioprotectors and suggests other parameters that may be exploited to find even better nitroxide-induced radioprotection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410280

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  17 in total

1.  Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators.

Authors:  Jean-Claude M Rwigema; Barbara Beck; Wei Wang; Alexander Doemling; Michael W Epperly; Donna Shields; Julie P Goff; Darcy Franicola; Tracy Dixon; Marie-Céline Frantz; Peter Wipf; Yulia Tyurina; Valerian E Kagan; Hong Wang; Joel S Greenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-13       Impact factor: 7.038

Review 2.  Treatment of Radiation Injury.

Authors:  Sadanori Akita
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-01-01       Impact factor: 4.730

3.  Synthesis and study of new paramagnetic and diamagnetic verapamil derivatives.

Authors:  Balázs Bognár; Shabnam Ahmed; M Lakshmi Kuppusamy; Karuppaiyah Selvendiran; Mahmood Khan; József Jeko; Olga H Hankovszky; Tamás Kálai; Periannan Kuppusamy; Kálmán Hideg
Journal:  Bioorg Med Chem       Date:  2010-02-25       Impact factor: 3.641

4.  Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic Diarylamines.

Authors:  Raghavan Rajagopalan; Tien-Sung Lin; Amolkumar S Karwa; Amruta R Poreddy; Bethel Asmelash; Richard B Dorshow
Journal:  ACS Med Chem Lett       Date:  2012-02-16       Impact factor: 4.345

5.  Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy.

Authors:  Zhentai Huang; Jianfei Jiang; Natalia A Belikova; Detcho A Stoyanovsky; Valerian E Kagan; Arlan H Mintz
Journal:  J Neurooncol       Date:  2010-09-12       Impact factor: 4.130

Review 6.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

7.  Evaluation of the fullerene compound DF-1 as a radiation protector.

Authors:  Aaron P Brown; Eun Joo Chung; Mary Ellen Urick; William P Shield; Anastasia L Sowers; Angela Thetford; Uma T Shankavaram; James B Mitchell; Deborah E Citrin
Journal:  Radiat Oncol       Date:  2010-05-11       Impact factor: 3.481

8.  Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent.

Authors:  Fuminori Hyodo; Kai-Hsiang Chuang; Artem G Goloshevsky; Agnieszka Sulima; Gary L Griffiths; James B Mitchell; Alan P Koretsky; Murali C Krishna
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-13       Impact factor: 6.200

Review 9.  The chemistry and biology of nitroxide compounds.

Authors:  Benjamin P Soule; Fuminori Hyodo; Ken-Ichiro Matsumoto; Nicole L Simone; John A Cook; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

Review 10.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.